{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:45:54Z","timestamp":1792291554525,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.prrv.2010.09.010","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T04:47:17Z","timestamp":1287118037000},"page":"31-38","source":"Crossref","is-referenced-by-count":61,"title":["Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians"],"prefix":"10.1016","volume":"12","author":[{"given":"H. Simon","family":"Schaaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2010.09.010_bib0005","unstructured":"World Health Organization. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland. WHO\/HTM\/TB\/2010.3."},{"key":"10.1016\/j.prrv.2010.09.010_bib0010","first-page":"636","article-title":"Global epidemiology of childhood tuberculosis","volume":"8","author":"Nelson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ccm.2009.08.019","article-title":"Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children","volume":"30","author":"Schaaf","year":"2009","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0020","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2105\/AJPH.2008.143271","article-title":"Surveillance of antituberculosis drug resistance amongst children from the Western Cape Province of South Africa \u2013 an upward trend","volume":"99","author":"Schaaf","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.prrv.2010.09.010_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0962-8479(94)90075-2","article-title":"Drug-resistant tuberculosis: issues in epidemiology and challenges for public health","volume":"75","author":"Rieder","year":"1993","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0030","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1128\/JCM.01291-06","article-title":"Beijing and Haarlem genotypes are over-represented among children with drug resistant tuberculosis in the Western Cape Province of South Africa","volume":"44","author":"Marais","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.prrv.2010.09.010_bib0035","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/adc.88.12.1106","article-title":"Culture-confirmed multidrug-resistant tuberculosis inchildren: diagnostic delay, clinical features, response to treatment and outcome","volume":"88","author":"Schaaf","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.prrv.2010.09.010_bib0040","first-page":"687","article-title":"Present aspects of bacterial resistance in tuberculosis","volume":"92","author":"Canetti","year":"1965","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0045","first-page":"125","article-title":"Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli","volume":"132","author":"Snider","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00006454-200008000-00005","article-title":"Transmission of multidrug resistant tuberculosis","volume":"19","author":"Schaaf","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0055","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.pmed.0040068","article-title":"Natural ventilation for the prevention of airborne contagion","volume":"4","author":"Escombe","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","author":"Kritski","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archpedi.1985.02140100042023","article-title":"Primary drug-resistant tuberculosis in children: Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis","volume":"139","author":"Steiner","year":"1985","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.prrv.2010.09.010_bib0070","first-page":"995","article-title":"Drug-resistant tuberculosis in children","volume":"97","author":"Schaaf","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0075","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland. WHO\/HTM\/TB\/2006.361."},{"key":"10.1016\/j.prrv.2010.09.010_bib0080","doi-asserted-by":"crossref","unstructured":"Mukherjee J, Schaaf HS. Multidrug-resistant tuberculosis in children. In: Tuberculosis: A Comprehensive Clinical Reference. Eds. H Simon Schaaf and Alimuddin Zumla. Saunders, Elsevier Publishers, London, UK 2009: 532\u2013538.","DOI":"10.1016\/B978-1-4160-3988-4.00052-4"},{"key":"10.1016\/j.prrv.2010.09.010_bib0085","unstructured":"World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO, Geneva, Switzerland. WHO\/HTM\/TB\/2006.371."},{"key":"10.1016\/j.prrv.2010.09.010_bib0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1542\/peds.2005-2623","article-title":"Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method","volume":"118","author":"Oberhelman","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2010.09.010_bib0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/rccm.200709-1436OC","article-title":"Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa","volume":"177","author":"Barnard","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0100","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JCM.00081-09","article-title":"Feasibility of the genotype MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens","volume":"47","author":"Hillemann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.prrv.2010.09.010_bib0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2010.09.010_bib0260","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(10)60554-5","article-title":"Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action","volume":"375","author":"Marais","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2010.09.010_bib0115","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1128\/JCM.00973-08","article-title":"Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates","volume":"46","author":"Mphahlele","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.prrv.2010.09.010_bib0120","first-page":"68","article-title":"Ethambutol resistance testing by mutation detection","volume":"10","author":"Johnson","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0125","first-page":"785","article-title":"Resistance to pyrazinamide and ethambutol compromises MDR\/XDR-TB treatment","volume":"99","author":"Hoek","year":"2009","journal-title":"S Afr Med J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0130","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008. WHO, Geneva, Switzerland, 2008. WHO\/HTM\/TB\/2008.402."},{"key":"10.1016\/j.prrv.2010.09.010_bib0265","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes of extensively drug-resistant tuberculosis in South Africa are poor regardless of HIV status","volume":"375","author":"Dheda","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2010.09.010_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/mdr.2006.12.7","article-title":"Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant mycobacterium tuberculosis: correlation with ofloxacin susceptibility","volume":"12","author":"Kam","year":"2006","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.prrv.2010.09.010_bib0145","first-page":"1355","article-title":"Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis","volume":"13","author":"Schaaf","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0150","first-page":"139","article-title":"A randomized controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis","volume":"12","author":"Katiyar","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1378\/chest.07-1988","article-title":"Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis","volume":"134","author":"Condos","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2010.09.010_bib0160","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/INF.0b013e31819bc491","article-title":"Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis","volume":"28","author":"Schaaf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jac\/dkp171","article-title":"Daily 300mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis","volume":"64","author":"Koh","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.prrv.2010.09.010_bib0170","first-page":"648","article-title":"Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis","volume":"5","author":"Furin","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0175","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1542\/peds.2005-2235","article-title":"Community-based therapy for children with multidrug-resistant tuberculosis","volume":"117","author":"Drobac","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2010.09.010_bib0180","first-page":"1318","article-title":"Ethambutol dosage for the treatment of children: literature review and recommendatiions","volume":"10","author":"Donald","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0185","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial disease","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prrv.2010.09.010_bib0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jtcvs.2007.03.022","article-title":"Lobectomy or pneumonectomy for multidrug-resistant tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience","volume":"134","author":"Mohsen","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.prrv.2010.09.010_bib0195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/09031936.00047208","article-title":"Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis","volume":"34","author":"Dravniece","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0200","doi-asserted-by":"crossref","DOI":"10.1111\/j.1651-2227.2010.01696.x","article-title":"Pyridoxal-5-phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid","author":"Cilliers","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.prrv.2010.09.010_bib0205","unstructured":"World Health Organization\/International Union Against Tuberculosis and Lung Health. Guidance for national HIV and tuberculosis programmes on the management of tuberculosis in HIV-infected children: recommendations for a public health approach. IUATLD, Paris, France. 2010."},{"key":"10.1016\/j.prrv.2010.09.010_bib0210","doi-asserted-by":"crossref","unstructured":"Schaaf HS, Nelson LJ. Tuberculosis drug therapy in children. In: Tuberculosis: A Comprehensive Clinical Reference. Eds. H Simon Schaaf and Alimuddin Zumla. Saunders, Elsevier Publishers, London, UK 2009: 627\u2013637.","DOI":"10.1016\/B978-1-4160-3988-4.00061-5"},{"key":"10.1016\/j.prrv.2010.09.010_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-8-1","article-title":"Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy","volume":"8","author":"Walters","year":"2008","journal-title":"BMC Pediatrics"},{"key":"10.1016\/j.prrv.2010.09.010_bib0220","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0225","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/INF.0b013e31814523e4","article-title":"Failure of chemoprophylaxis with standard anti-tuberculosis agents in child contacts of multidrug-resistant tuberculosis cases","volume":"26","author":"Sneag","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1378\/chest.106.2.431","article-title":"Preventive therapy for contacts of multidrug-resistant tuberculosis","volume":"106","author":"Passanante","year":"1994","journal-title":"A Delphi survey. Chest"},{"key":"10.1016\/j.prrv.2010.09.010_bib0235","first-page":"S221","article-title":"Centers for Disease Control and Prevention and Infectious Disease Society of America. Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0240","unstructured":"American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Long SS, McMilan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th Ed, Elk Grove Village, IL. American Academy of Pediatrics 2006:678\u2013704."},{"key":"10.1016\/j.prrv.2010.09.010_bib0245","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.inf.0000173305.04212.09","article-title":"Adult-type pulmonary tuberculosis in children 10-14 years of age","volume":"24","author":"Marais","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prrv.2010.09.010_bib0250","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199911113412002","article-title":"Extensive transmission of Mycobacterium tuberculosis from a child","volume":"341","author":"Curtis","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2010.09.010_bib0255","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/501972","article-title":"Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children's hospital","volume":"23","author":"Munoz","year":"2002","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054210000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054210000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T10:23:04Z","timestamp":1559730184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054210000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1526054210000783"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2010.09.010","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}